Company: NCEL
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065783
Chunk: 481

Company: NewcelX Ltd.
Filing Date: 2025-07-18
Form: F-4/A
Chunk 481
---
, organizational rules, etc.), (b) oversee and verify annual performance evaluations of the NLS Board and committees, (c) evaluate its own performance annually and (d) keep the NLS Board informed of actions other than routine or administrative actions. With regard to adjustments to articles of association:propose changes related to remuneration and governance matters for NLS Board approval, to be ultimately approved by shareholders. With regard to the Compensation Committee Charter:review the Charter annually and recommend any changes to the NLS Board. The charter is subject to review and modification from time to time by the NLS Board as it may deem appropriate and in the best interests of the Company and its shareholders. The Compensation Committee reports regularly to the NLS Board on decisions, proposals, and non -routineitems within its remit. 258

EXECUTIVE COMPENSATION AND SHARE OWNERSHIP Kadimastem’s Employment Agreements and Indemnification Agreements Kadimastem has entered into employment agreements with each of its executive officers, which set forth the terms and conditions of each executive’s employment, including base salary, performance -basedvariable pay compensation and benefit plan participation. Under these agreements, each of its executive officers is employed for a specified time period. Kadimastem and/or its subsidiaries may terminate employment without notice, at any time, for certain acts of the executive officer, such as serious, repeated or continuing breach of internal policies or guidelines on conduct, any act or conduct which would bring the officer or Kadimastem into disrepute, any serious misconduct, unreasonable absenteeism or willful disobedience of Kadimastem lawful orders, willful refusal to perform all or any duties, insubordination, breach of Kadimastem secrecy, or violation of the laws and regulations of Israel. Kadimastem and/or its subsidiaries may also terminate an executive officer’s employment with advanced written notice. The length of such notice period is set out in each contract in accordance with the applicable law of Israel. Without delivering an advanced written notice, Kadimastem may also terminate an executive officer’s employment by paying to such officer salary in lieu of notice for the remainder of the relevant notice period. The executive officer may resign at any time by delivering to Kadimastem an advanced written notice. There are no severance provisions contained in these agreements. Kadimastem has entered into indemnification agreements with each of its directors and executive officers. Under these agreements, and subject to the terms thereof being in compliance with the